Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Radspherin by Oncoinvent for Peritoneal Cancer: Likelihood of Approval
Radspherin is under clinical development by Oncoinvent and currently in Phase II for Peritoneal Cancer. According to GlobalData, Phase II...
Radspherin by Oncoinvent for Fallopian Tube Cancer: Likelihood of Approval
Radspherin is under clinical development by Oncoinvent and currently in Phase II for Fallopian Tube Cancer. According to GlobalData, Phase...
Radspherin by Oncoinvent for Epithelial Ovarian Cancer: Likelihood of Approval
Radspherin is under clinical development by Oncoinvent and currently in Phase II for Epithelial Ovarian Cancer. According to GlobalData, Phase...
Radspherin by Oncoinvent for Colorectal Cancer: Likelihood of Approval
Radspherin is under clinical development by Oncoinvent and currently in Phase II for Colorectal Cancer. According to GlobalData, Phase II...
Radspherin by Oncoinvent for Carcinomas: Likelihood of Approval
Radspherin is under clinical development by Oncoinvent and currently in Phase II for Carcinomas. According to GlobalData, Phase II drugs...